Priority attention to non-Covid patients, especially oncological and chronic, in order not to lose the progress achieved in the last 20 years in terms of prevention and treatment. Ease of access to health services and medicines to reduce inequalities and “leave no one behind”.
Investments to have more resilient health services and to support research for more equitable access to care and to address unmet health needs. Strong reference to the sense of responsibility at all institutional levels in order to transform into acts the spirit of solidarity between countries which is a precondition for dealing with crises worldwide.
These, in summary, are the main messages hosted in the video created by Active Citizenship Network, the European branch of the Italian NGO Cittadinanzattiva, and addressed to the political leaders and experts gathered today in Rome on the occasion of the Global Health Summit, co-organized by the European Commission and Italy as chair of the G20. Here is the link to the video
The role of civic society and Patients Advocacy Groups for more resilient Health Care Systems. 10 recommendations towards a European Health Union
In the role of needed changes towards more resilient healthcare systems, it is necessary to recognize the key role of Patients' Advocacy groups (PAGs), citizens’ organizations involved in healthcare issues and, more generally, of all actors that promote health as a common good. This is the message that came to light during the European conference of the 15th European Patients’ Rights Day, which started today and will end tomorrow, involving more than 150 civic society representatives from across Europe, members of the European Institutions and key stakeholders.
The event is promoted by Active Citizenship Network, the European branch of the Italian non profit organization Cittadinanzattiva. and has been realized thanks to the unconditional support of: F. Hoffmann-La Roche LTD, Teva Europe, Boehringer Ingelheim International GmbH and Viatris.
Rome, 15February 2021
Civil society organizations, together with European Institutions to contribute to the achievement of the Sustainable Development Goals (SDGs): this is the main message of the new political initiative that will be launched at the European level, tomorrow, the 16th February, in the occasion of the conference “Making sustainability an easy choice for EU citizens”.
Promoted by Cittadinanzattiva – through its European branch Active Citizenship Network (ACN) – by the European Consumers Union association (ECU) and by the Italian Alliance for Sustainable Development (ASviS), theInter-Institutional Group “SDG’s for well-being and consumers’ protection” is currently supported by eight Members of the European Parliament (MEPs) from different countries and political groups: Nikos Androulakis (Greece – S&D); Tanja Fajon (Slovenia – S&D); Jose Gusmão (Portugal – GUE/NGL); Aldo Patriciello (Italy – EPP); Sabrina Pignedoli (Italy – NI); Giuliano Pisapia (Italy – S&D); Marcos Ros Sempere (Spain - S&D); Patrizia Toia (Italy – S&D).
Brussels, 19 November 2020
Antimicrobial resistance: one of the ten most urgent threats for the Global Health but totally underestimated among the populations; more dangerous than car accidents & cancer but not enough prioritized in the EU and National public health policies. Interlinked with Covid-19 pandemic but almost ignored by the media. The world is losing its most powerful tool in healthcare: antibiotics. By 2050 super bacteria could cause 350 million of deaths and meantime research is still waiting for EU incentive mechanisms as well as an overall strategy to integrate the development of - and access to - affordable and quality antimicrobials.
Despite the fight against AMR requires policies focused on the prevention and extension of vaccinations, the health expenditure for prevention programmes are the “Cinderella” of the public health budget.
“We were not born to suffer": this is the name of the campaign launched today by Cittadinanzattiva, ten years after the law 38/2010 which regulates access to palliative care and pain therapy and which puts our country in a leading position for citizens' rights.
4 best practices activities have been awarded today in Brussels, thanks to the second edition of the “EU Civic prize on Chronic Pain”, promoted by the Italian NGO Active Citizenship Network-Cittadinanzattiva during the annual symposium on the “Societal Impact of Pain” (SIP).
Active Citizenship Network (ACN) launched the project ”EU Civic Prize on Chronic Pain - Collecting good practices” to give evidence of the existing good practices in Europe in terms of struggle against pain, and based on the selection of the practices presented by different healthcare stakeholders. The prize provided an occasion for demonstrating what the community can offer in terms of good practices as well as sharing experiences useful for raising awareness about the condition, enhancing the body of knowledge of positive cases and success, and strengthening commitment on this topic. Throughout 2018 and 2019, this initiative has allowed us to collect 40 Good Practices coming from 12 different countries: Spain (13), Italy (10), Portugal (5) Belgium (3), France (2), Malta (1), Sweden (1), Germany (1), The Netherlands (1), Ireland (1), UK (1), and an extra EU country (1 from the Dominican Republic).
Delivering patient value throughout the healthcare system
Focus on Digital Health and Personalized Medicine
Patient access to digital health innovation must be a shared responsibility of all the stakeholders involved in the health sector: private and public bodies have to collaborate.
In view of the next European elections, we ask more certainties that Digital Health and Personalized Medicine will be considered by the European Institutions among the priorities for the next years.
Delivering patient value throughout the healthcare system: a debate on citizens' expectations
The civic society and patients’ advocacy groups committed to improve health and well-being across Europe are aware that the political context following the upcoming European elections could be characterized by less or no significant EU action on health. This is not how it should be. Citizens and patients are political actors who understand and recognize the advantages of having a strong and harmonized European health policy.
“European Consumer Union”: New EU consumer organization officially presented at the EU Parliament
“European Consumer Union”, the new EU umbrella consumer association, was officially presented in Brussels to the EU Institutions (EU Commission, members of the European parliament and of the European Economic Social Committee) and other relevant stakeholders.
The launch event took place last 5th of March at the EU Parliament in the conference entitled “Towards EU election: Strengthening the European Union for a more effective consumer protection,” hosted by Italian MEP Viotti, S&D.
An event promoted by Active Citizenship Network-Cittadinanzattiva on February 4th and 5th, 2019, in Brussels.
In order to effectively fight against healthcare associated infections (HAIs) and antimicrobial resistance (AMR), it is necessary to adopt innovative solutions together with a decisive action aiming at raising awareness of this issue among the public. Therefore, it is pivotal to engage groups advocating for patients’ rights. This is the message that emerges from a two-day event devoted to patient safety, organized on the 4th and 5th of February in Brussels by Active Citizenship Network, the European network of Cittadinanzattiva, with the support of Copma. Indeed, recent data released by the European Center for Infectious Diseases (ECDC) have reported that the problem of antibiotic-resistant infections is worsening. In Europe, about 33,000 deaths per year are caused by this kind of infections, and almost a third of these occur in Italy. Here, despite the high incidence of this phenomenon, there is a very low level of awareness of the risks associated with HAIs and AMR. Proper prevention practices, together with the adoption of innovative solutions, could significantly curb HAIs, and consequently economically benefit the national health system. As a matter of fact, the costs for treating each single infection range from 5.000 to 9.000 euros.